PHOENIX, Ariz. – December 5, 2023 – Life365, a leader in transforming healthcare through innovative solutions, announce today the acquisition of AffirmXH, a company renowned for its advanced biometric data analysis and no-code digital treatment platforms. The acquisition was completed under the LifeConnect division, and signifies a major step in expanding their reach in health monitoring.
AffirmXH specializes in gathering, analyzing, and responding to biometric data, employing a bio-sensor, drag-and-drop treatment builder, and algorithm development. Their products align with LifeConnect’s goal of providing high-quality health monitoring solutions.
A key product from AffirmXH, the Continuous Temperature Sensor, offers over 50 temperature readings per hour through a disposable, maintenance-free patch, showcasing the company’s commitment to user-friendly and efficient health monitoring technologies. This acquisition allows Life365 to incorporate these advanced technologies into its LifeConnect division, enhancing their ability to deliver personalized and effective healthcare solutions.
“Our goal is to make AI-driven health monitoring accessible to a wider audience,” stated Kent Dicks, CEO of Life365. “With AffirmXH’s innovative technology, and LifeConnect’s expertise, we are poised to redefine how health monitoring is delivered.”
For more information, please visit Life365 at life365.health.
END
Contact Information:
Randy Strength
Chief Creative Officer
Life365
randy.strength@life365.health
888-818-2322 x701